Eli Lilly and Company (NYSE:LLY) is one of the 13 Best Low Risk High Growth Stocks to Buy. Amid carrying on new studies, the company has agreed to acquire Verve Therapeutics. Eli Lilly and Company ...

Liupao tea shows promise in improving metabolic syndrome markers, enhancing heart health and gut balance in just three months ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

Dogs' noses are sensitive enough to track down fleeing convicts, locate human remains in hidden burial sites and detect ...

What makes the human brain distinctive? A new study published July 21 in Cell identifies two genes linked to human brain features and provides a road map to discover many more. The research could lead ...

Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability ...

A new study reveals how Doubling-Back Aversion leads people to reject smarter choices just to avoid undoing past progress.

Dogs can be trained to reliably sniff out Parkinson’s disease from a person’s sebum, or skin secretions, a new study found.

Birth of a Nation” (2025) by Stan Douglas. The Canadian artist remakes a sequence from the 1915 movie with new ...

Prospective, randomized, multicenter, double-blind studies failed to confirm the benefits in mortality for patients receiving G-CSF for the treatment of severe sepsis and septic shock.

VERONA is a global, AbbVie-led, Phase III, multicenter, randomized, double-blind study evaluating Venclexta in combination with azacitidine compared to placebo plus azacitidine in treatment-naïve ...

The incidence of hematologic toxicity in the present series differs from the results of a recent study, in which no hematologic abnormalities were observed in 95 patients given "maximum" doses ...